File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/pmic.200402027
- Scopus: eid_2-s2.0-31344472931
- PMID: 16287165
- WOS: WOS:000234764800014
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Proteomic characterization of the cytotoxic mechanism of gold (III) porphyrin 1a, a potential anticancer drug
Title | Proteomic characterization of the cytotoxic mechanism of gold (III) porphyrin 1a, a potential anticancer drug |
---|---|
Authors | |
Keywords | Anticancer drug Apoptosis Gold compound Protein profiling |
Issue Date | 2006 |
Publisher | Wiley - V C H Verlag GmbH & Co KGaA. The Journal's web site is located at http://www.wiley-vch.de/home/proteomics |
Citation | Proteomics, 2006, v. 6 n. 1, p. 131-142 How to Cite? |
Abstract | There has been increasing interest in the potential applications of gold (III) complexes as anticancer drugs with higher cytotoxicity and fewer side effects than existing metal anticancer drugs. Our previous findings demonstrated that gold (III) porphyrin la preferentially induced apoptosis in a cancer cell line (SUNE1). In this study, we identified differentially expressed proteins related to the drug's cytotoxic action by comparing the protein alterations induced by gold (III) porphyrin la and cisplatin treatments. Several clusters of altered proteins were identified, including cellular structure and stress-related chaperone proteins, proteins involved in reactive oxygen species and enzyme proteins, translation factors, proteins that mediate cell proliferation or differentiation, and proteins participating in the internal degradation systems. Our results indicated that multiple factors leading to apoptosis were involved in drug cytotoxicity in SUNE1 cells. The balance between pro-apoptotic and anti-apoptotic signals determined the final fate of cancer cells. © 2006 Wiley-VCH Verlag GmbH & Co. KGaA. |
Persistent Identifier | http://hdl.handle.net/10722/48512 |
ISSN | 2023 Impact Factor: 3.4 2023 SCImago Journal Rankings: 1.011 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wang, Y | en_HK |
dc.contributor.author | He, QY | en_HK |
dc.contributor.author | Che, CM | en_HK |
dc.contributor.author | Chiu, JF | en_HK |
dc.date.accessioned | 2008-05-22T04:15:53Z | - |
dc.date.available | 2008-05-22T04:15:53Z | - |
dc.date.issued | 2006 | en_HK |
dc.identifier.citation | Proteomics, 2006, v. 6 n. 1, p. 131-142 | en_HK |
dc.identifier.issn | 1615-9853 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/48512 | - |
dc.description.abstract | There has been increasing interest in the potential applications of gold (III) complexes as anticancer drugs with higher cytotoxicity and fewer side effects than existing metal anticancer drugs. Our previous findings demonstrated that gold (III) porphyrin la preferentially induced apoptosis in a cancer cell line (SUNE1). In this study, we identified differentially expressed proteins related to the drug's cytotoxic action by comparing the protein alterations induced by gold (III) porphyrin la and cisplatin treatments. Several clusters of altered proteins were identified, including cellular structure and stress-related chaperone proteins, proteins involved in reactive oxygen species and enzyme proteins, translation factors, proteins that mediate cell proliferation or differentiation, and proteins participating in the internal degradation systems. Our results indicated that multiple factors leading to apoptosis were involved in drug cytotoxicity in SUNE1 cells. The balance between pro-apoptotic and anti-apoptotic signals determined the final fate of cancer cells. © 2006 Wiley-VCH Verlag GmbH & Co. KGaA. | en_HK |
dc.format.extent | 1738507 bytes | - |
dc.format.extent | 254114 bytes | - |
dc.format.mimetype | application/pdf | - |
dc.format.mimetype | application/pdf | - |
dc.language | eng | en_HK |
dc.publisher | Wiley - V C H Verlag GmbH & Co KGaA. The Journal's web site is located at http://www.wiley-vch.de/home/proteomics | en_HK |
dc.relation.ispartof | Proteomics | en_HK |
dc.rights | Published in Proteomics, 2006, v. 6 n. 1, p. 131-142 | en_HK |
dc.subject | Anticancer drug | en_HK |
dc.subject | Apoptosis | en_HK |
dc.subject | Gold compound | en_HK |
dc.subject | Protein profiling | en_HK |
dc.title | Proteomic characterization of the cytotoxic mechanism of gold (III) porphyrin 1a, a potential anticancer drug | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1615-9853&volume=6&issue=1&spage=131&epage=142&date=2006&atitle=Proteomic+characterization+of+the+cytotoxic+mechanism+of+gold+(III)+porphyrin+1a,+a+potential+anticancer+drug | en_HK |
dc.identifier.email | Che, CM:cmche@hku.hk | en_HK |
dc.identifier.authority | Che, CM=rp00670 | en_HK |
dc.description.nature | postprint | en_HK |
dc.identifier.doi | 10.1002/pmic.200402027 | en_HK |
dc.identifier.pmid | 16287165 | en_HK |
dc.identifier.scopus | eid_2-s2.0-31344472931 | en_HK |
dc.identifier.hkuros | 113901 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-31344472931&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 6 | en_HK |
dc.identifier.issue | 1 | en_HK |
dc.identifier.spage | 131 | en_HK |
dc.identifier.epage | 142 | en_HK |
dc.identifier.isi | WOS:000234764800014 | - |
dc.publisher.place | Germany | en_HK |
dc.identifier.scopusauthorid | Wang, Y=7601510411 | en_HK |
dc.identifier.scopusauthorid | He, QY=34770287900 | en_HK |
dc.identifier.scopusauthorid | Che, CM=7102442791 | en_HK |
dc.identifier.scopusauthorid | Chiu, JF=7201501692 | en_HK |
dc.identifier.issnl | 1615-9853 | - |